024 Psoriasis Stratification to Optimise Relevant Therapy (PSORT): Clinical and demographic predictors of biologic response for psoriasis

Richard B. Warren; David Burden; Barbara Tomenson; Moetaza M. Soliman; Richard Emsley; Christopher Em Griffiths; Catherine Smith

doi:10.1016/j.jid.2016.06.041

Related publications

Article2018

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study

Richard B. Warren, Antonia Marsden, Barbara Tomenson, K.J. Mason, Moetaza M. Soliman, A. David Burden, Nick J. Reynolds, Deborah Stocken, Richard Emsley, Christopher Em Griffiths, Catherine Smith

Article2021

Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase

Zenas Z N Yiu, Juliet N. Barker, Michael R. Barnes, Paola Di Meglio, Richard Emsley, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Christopher Em Griffiths

Editorial Material2015

Establishing an Academic–Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy

Christopher Em Griffiths, Michael R. Barnes, A. David Burden, Frank O. Nestlé, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Juliet N. Barker

Article2018

A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis

Amy Foulkes, David Watson, Daniel F. Carr, John Kenny, Timothy Slidel, Richard Parslew, Munir Pirmohamed, Simon Anders, Nick J. Reynolds, Christopher Em Griffiths, Richard B. Warren, Michael R. Barnes

Article2014

Pharmacogenomic signatures of response to etanercept therapy for psoriasis

AC Foulkes, DF Carr, Ali Alsharqi, Richard Parslew, Munir Pirmohamed, NJ Reynolds, MJ Donaldson, Michael R. Barnes, Christopher Em Griffiths, Richard B. Warren